The role of ifosfamide in the treatment of lymphomas.

@article{Hagemeister1999TheRO,
  title={The role of ifosfamide in the treatment of lymphomas.},
  author={Fredrick B. Hagemeister},
  journal={Leukemia & lymphoma},
  year={1999},
  volume={34 5-6},
  pages={
          433-41
        }
}
Over the last few decades, progress has been made in classification and treatment guidelines for patients with lymphoma with differing prognostic factors. As investigators look for alternatives to current standard therapy there has been a resurgence of interest in the alkylating agent ifosfamide. A basic tenet of lymphoma therapy has been to use combinations of non-cross resistant agents in an effort to avoid tumor resistance. Ifosfamide is at least partially non-cross resistant with… CONTINUE READING